News
Jessica Zbinden-Webster was diagnosed with a rare kind of basal cell carcinoma when she was just 26, now she campaigns to ...
Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...
Bristol Myers Squibb said the Food and Drug Administration approved Opdivo plus Yervoy as a first-line treatment for certain types of carcinoma.
The FDA has approved Opdivo with Yervoy for the first-line treatment of adults with unresectable or metastatic hepatocellular ...
Officials have determined what killed actor Val Kilmer. According to the death certificate, the “Top Gun” actor died of ...
Val Kilmer’s cause of death has been revealed. The beloved actor, who passed away April 1 at 65, died from pneumonia. A death ...
During a live event, Benjamin Garmezy, MD, discussed combinations regimens used for patients with renal cell carcinoma after ...
Influencer Sidney Raz shared that he has been diagnosed with stomach cancer nearly seven months after his daughter died in ...
A clinical trial for patients with high-grade neuroendocrine tumors is now open for enrollment at Sylvester Comprehensive Cancer Center, part of the University of Miami Miller School of Medicine.
Announced an agreement with F. Hoffmann-La Roche Ltd. (Roche) to advance the evaluation of amezalpat in combination with atezolizumab and bevacizumab into a pivotal Phase 3 trial for the first-line ...
A phase 1b trial is evaluating PH-762 for the treatment of cutaneous squamous cell carcinoma, melanoma and Merkel cell ...
Younger age, substance use, and HCC may be risk factors for repeat HCV viremia in patients who achieve SVR following DAA therapy.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results